Back to Journals » Therapeutics and Clinical Risk Management » Volume 16

Therapeutics and Clinical Risk Management


Archive: Volume 16, 2020

Health-Related Quality of Life in Patients After Surgically Treated Midface Fracture: A Comparison with the Croatian Population Norm

Lupi-Ferandin S, Glumac S, Poljak N, Galic T, Ivkovic N, Brborovic O, Pecotic R, Dogas Z

Therapeutics and Clinical Risk Management 2020, 16:261-267

Published Date: 9 April 2020

Hypophosphatemia Associated with Intravenous Iron Therapies for Iron Deficiency Anemia: A Systematic Literature Review

Glaspy JA, Lim-Watson MZ, Libre MA, Karkare SS, Hadker N, Bajic-Lucas A, Strauss WE, Dahl NV

Therapeutics and Clinical Risk Management 2020, 16:245-259

Published Date: 8 April 2020

Changing Times for CLN2 Disease: The Era of Enzyme Replacement Therapy

Specchio N, Pietrafusa N, Trivisano M

Therapeutics and Clinical Risk Management 2020, 16:213-222

Published Date: 30 March 2020

Efficacy and Safety of Epilepsy Surgery for Older Adult Patients with Refractory Epilepsy

Ichikawa N, Fujimoto A, Okanishi T, Sato K, Enoki H

Therapeutics and Clinical Risk Management 2020, 16:195-199

Published Date: 25 March 2020

Estimation of Risk Factors for Head Slippage Using a Head Clamp System. A Retrospective Study

Sakakura K, Fujimoto A, Ichikawa N, Ishikawa E, Matsumura A, Enoki H, Okanishi T

Therapeutics and Clinical Risk Management 2020, 16:189-194

Published Date: 25 March 2020

Repair Method for Complete High Ulnar Nerve Injury Based on Nerve Magnified Regeneration

Ding W, Li X, Pan J, Zhang P, Yin S, Zhou X, Li J, Wang L, Wang X, Dong J

Therapeutics and Clinical Risk Management 2020, 16:155-168

Published Date: 3 March 2020

A Single Episode of Hypoglycemia as a Possible Early Warning Sign of Adrenal Insufficiency

Tanaka S, Abe M, Kohno G, Kushimoto M, Ikeda J, Ogawa K, Suzuki Y, Ishihara H, Fujishiro M

Therapeutics and Clinical Risk Management 2020, 16:147-153

Published Date: 27 February 2020

Metastatic Hepatic Epithelioid Hemangioendothelioma Treated with Olaratumab: A Falling Star Rising?

Kyriazoglou A, Koutsoukos K, Zagouri F, Liontos M, Dimitriadis E, Tiniakos D, Dimopoulos MA

Therapeutics and Clinical Risk Management 2020, 16:141-146

Published Date: 27 February 2020

Lateral Position versus Prone Position for Cervical Laminoplasty: A Retrospective Comparative Study

Du L, Gao Y, Gao K, Yang G, Gao S

Therapeutics and Clinical Risk Management 2020, 16:133-140

Published Date: 21 February 2020

Incidence, Predictors, and Prognosis of Coronary Slow-Flow and No-Reflow Phenomenon in Patients with Chronic Total Occlusion Who Underwent Percutaneous Coronary Intervention

Wang Y, Zhao H, Wang C, Zhang X, Tao J, Cui C, Meng Q, Zhu Y, Luo D, Hou A, Luan B

Therapeutics and Clinical Risk Management 2020, 16:95-101

Published Date: 18 February 2020

Mirror Therapy in Stroke Rehabilitation: Current Perspectives

Gandhi DBC, Sterba A, Khatter H, Pandian JD

Therapeutics and Clinical Risk Management 2020, 16:75-85

Published Date: 7 February 2020

Uric Acid and Arterial Stiffness

Albu A, Para I, Porojan M

Therapeutics and Clinical Risk Management 2020, 16:39-54

Published Date: 28 January 2020

Advanced Ultrasound Application – Impact on Presurgical Risk Stratification of the Thyroid Nodules

Stoian D, Ivan V, Sporea I, Florian V, Mozos I, Navolan D, Nemescu D

Therapeutics and Clinical Risk Management 2020, 16:21-30

Published Date: 21 January 2020

Rapidly Destructive Coxarthrosis as a Potential Side Effect of Crizotinib in a Patient with ROS1-Positive Lung Adenocarcinoma

Takamori S, Seto T, Jinnouchi M, Oba T, Yamaguchi M, Takenoyama M

Therapeutics and Clinical Risk Management 2020, 16:17-20

Published Date: 17 January 2020